Pfizer Inc Free Cash Flow Generation Index
Pfizer Inc free cash flow generation index. Pfizer Inc (PFIZ34) has a Free Cash Flow Generation Index of 0.36x as of June 2026. Free cash flow of R$302.00 Million represents 0% of operating cash flow (R$835.00 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Pfizer Inc (2014–2025)
Free cash flow generation index of Pfizer Inc from 2014 to 2025. Historical FCF Generation Index trend for Pfizer Inc across 12 annual periods. See Pfizer Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Pfizer Inc Free Cash Flow Generation Index by Year (2014–2025)
Pfizer Inc free cash flow generation index by year from 2014 to 2025. Year-by-year Free Cash Flow Generation Index for Pfizer Inc. For the full cash flow conversion analysis, see PFIZ34 operating cash flow.
| Year | FCG Index | Free Cash Flow (BRL) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | R$9.07 Billion | R$11.71 Billion | R$2.63 Billion | ▲ +0.5% |
| 2024 | 0.77x | R$9.84 Billion | R$12.74 Billion | R$2.91 Billion | ▲ +13.6% |
| 2023 | 0.68x | R$8.18 Billion | R$12.04 Billion | R$3.86 Billion | ▼ -23.6% |
| 2022 | 0.89x | R$26.03 Billion | R$29.27 Billion | R$3.24 Billion | ▼ -3.0% |
| 2021 | 0.92x | R$29.87 Billion | R$32.58 Billion | R$2.71 Billion | ▲ +13.7% |
| 2020 | 0.81x | R$11.61 Billion | R$14.40 Billion | R$2.79 Billion | ▲ +1.5% |
| 2019 | 0.79x | R$9.99 Billion | R$12.59 Billion | R$2.59 Billion | ▼ -7.8% |
| 2018 | 0.86x | R$13.63 Billion | R$15.83 Billion | R$2.20 Billion | ▲ +1.5% |
| 2017 | 0.85x | R$14.25 Billion | R$16.80 Billion | R$2.22 Billion | ▼ -24.5% |
| 2016 | 1.12x | R$18.19 Billion | R$16.19 Billion | R$2.00 Billion | ▲ +2.6% |
| 2015 | 1.10x | R$16.09 Billion | R$14.69 Billion | R$1.40 Billion | ▲ +2.3% |
| 2014 | 1.07x | R$18.28 Billion | R$17.08 Billion | R$1.20 Billion | — |